Loading…
EURAX HYDROCORTISONE is a brand name for Hydrocortisone. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Eczema and dermatitis of all types including atopic eczema, photodermatitis, otitis externa, primary irritant and allergic dermatitis, intertrigo, prurigo nodularis, seborrhoeic dermatitis and insect bite reactions. Route of Administration: Cutaneous use.
Verbatim from this product's MHRA label. Tap a section to expand.
Adults A thin layer of Eurax Hydrocortisone Cream should be applied to the affected area 2-3 times a day. Occlusive dressings should not be used. Treatment should be limited to 10-14 days or up to 7 days if applied to the face. Use in the Elderly Clinical evidence would indicate that no special dosage regime is necessary.
Paediatric population:
Eurax Hydrocortisone Cream should be used with caution in infants, particularly when used in the nappy region, and for not more than 7 days unless under medical supervision. Eurax Hydrocortisone Cream should not be applied more than once a day to large areas of the body surface in young children.
See section
Adverse reactions are listed below by frequency. Frequencies are defined as: uncommon (>1/1,000 to < 1/100), rare (> 1/10,000 to < 1/1,000) and very rare (<1/10,000).
Skin and subcutaneous tissue disorders:
Uncommon: pruritus Rare: contact dermatitis, hypersensitivity (including/like rash, eczema, erythema, skin irritation, angioedema) Treatment should be discontinued if severe irritation occurs. In case of longer lasting administration skin atrophy, telangiectasia, striae, steroid induced acne, peroral dermatitis and hypertrichosis cannot be excluded.
4) Skin and Subcutaneous Tissue Disorders Not known (cannot be estimated from available data) Withdrawal reactions - redness of the skin which may extend to areas beyond the initial affected area, burning or stinging sensation, itch, skin peeling, oozing pustules.
4) Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store.
Method of administration:
For cutaneous use. 1, List of excipients). Bacterial, viral or fungal infections of the skin. Acute exudative dermatoses. Application to ulcerated areas. 4 Special warnings and precautions for use Eurax Hydrocortisone Cream is for external use only.
Caution should be used when applying the cream to infants and for not more than 7 days without medical supervision. Long-term continuous topical therapy should be avoided since this can lead to adrenal suppression even without occlusion.
Occlusive dressings should not be used. Avoid using a nappy if Eurax Hydrocortisone Cream is applied in the nappy region and restrict to one application per day if applied to a large area. Eurax Hydrocortisone Cream should not be used in buccal mucosa or other mucous membranes and in or around the eyes since contact with the eyelids may give rise to conjunctival inflammation.
In case of accidental contact with the eyes, or mucosa rinse thoroughly with running water. Eurax Hydrocortisone Cream should not be applied in the presence of exudative wounds, broken skin, or very inflamed skin. g. contact dermatitis); propyl parahydroxybenzoate(E216) and methyl parahydroxybenzoate (E218) which may cause allergic reactions (possibly delayed).
This medicine contains 200mg propylene glycol (E1520) in each gram of cream. This medicine contains fragrance with benzyl alcohol, benzyl benzoate, citral, citronellol, coumarin, d-limonene, eugenol, geraniol and linalool which may cause allergic reactions.
Eurax Hydrocortisone Cream should only be used during pregnancy or breast- feeding under medical supervision Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.
1, List of excipients). Bacterial, viral or fungal infections of the skin. Acute exudative dermatoses. Application to ulcerated areas.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Hydrocortisone in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
Instruct patients not to smoke or go near naked flames – risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it Long term use of topical steroids can result in the development of rebound flares after stopping treatment (topical steroid withdrawal syndrome).
A severe form of rebound flare can develop which takes the form of a dermatitis with intense redness, stinging and burning that can spread beyond the initial treatment area. It is more likely to occur when delicate skin sites such as the face and flexures are treated.
Should there be a reoccurrence of the condition within days to weeks after successful treatment a withdrawal reaction should be suspected. Reapplication should be with caution and specialist advise is recommended in these cases or other treatment options should be considered.
The label will state mild steroid.